» Articles » PMID: 19675183

Regulation of Rat Intestinal Na-dependent Phosphate Transporters by Dietary Phosphate

Overview
Specialties Nephrology
Physiology
Date 2009 Aug 14
PMID 19675183
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Hyperphosphatemia associated with chronic kidney disease is one of the factors that can promote vascular calcification, and intestinal P(i) absorption is one of the pharmacological targets that prevents it. The type II Na-P(i) cotransporter NaPi-2b is the major transporter that mediates P(i) reabsorption in the intestine. The potential role and regulation of other Na-P(i) transporters remain unknown. We have identified expression of the type III Na-P(i) cotransporter PiT-1 in the apical membrane of enterocytes. Na-P(i) transport activity and NaPi-2b and PiT-1 proteins are mostly expressed in the duodenum and jejunum of rat small intestine; their expression is negligible in the ileum. In response to a chronic low-P(i) diet, there is an adaptive response restricted to the jejunum, with increased brush border membrane (BBM) Na-P(i) transport activity and NaPi-2b, but not PiT-1, protein and mRNA abundance. However, in rats acutely switched from a low- to a high-P(i) diet, there is an increase in BBM Na-P(i) transport activity in the duodenum that is associated with an increase in BBM NaPi-2b protein abundance. Acute adaptive upregulation is restricted to the duodenum and induces an increase in serum P(i) that produces a transient postprandial hyperphosphatemia. Our study, therefore, indicates that Na-P(i) transport activity and NaPi-2b protein expression are differentially regulated in the duodenum vs. the jejunum and that postprandial upregulation of NaPi-2b could be a potential target for treatment of hyperphosphatemia.

Citing Articles

Dietary Phosphorus Levels Influence Protein-Derived Uremic Toxin Production in Nephrectomized Male Rats.

Cladis D, Burstad K, Biruete A, Jannasch A, Cooper B, Hill Gallant K Nutrients. 2024; 16(12).

PMID: 38931160 PMC: 11207110. DOI: 10.3390/nu16121807.


Effect of an NHE3 inhibitor in combination with an NPT2b inhibitor on gastrointestinal phosphate absorption in Rodent models.

Wang X, Yu X, Gavardinas K, Dey A, Zhang H, Porter G PLoS One. 2024; 19(1):e0292091.

PMID: 38277356 PMC: 10817170. DOI: 10.1371/journal.pone.0292091.


Phosphate in Cardiovascular Disease: From New Insights Into Molecular Mechanisms to Clinical Implications.

Turner M, Beck L, Hill Gallant K, Chen Y, Moe O, Kuro-O M Arterioscler Thromb Vasc Biol. 2024; 44(3):584-602.

PMID: 38205639 PMC: 10922848. DOI: 10.1161/ATVBAHA.123.319198.


Intestinal and Renal Adaptations to Changes of Dietary Phosphate Concentrations in Rat.

Lucea S, Chopo-Escuin G, Guillen N, Sosa C, Sorribas V Function (Oxf). 2023; 5(1):zqad063.

PMID: 38033458 PMC: 10686248. DOI: 10.1093/function/zqad063.


Intestinal segment and vitamin D concentration affect gene expression levels of calcium and phosphorus transporters in broiler chickens.

Han J, Wu L, Lv X, Liu M, Zhang Y, He L J Anim Sci Technol. 2023; 65(2):336-350.

PMID: 37093912 PMC: 10119455. DOI: 10.5187/jast.2022.e78.


References
1.
Nishida Y, Taketani Y, Yamanaka-Okumura H, Imamura F, Taniguchi A, Sato T . Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men. Kidney Int. 2006; 70(12):2141-7. DOI: 10.1038/sj.ki.5002000. View

2.
Ravera S, Virkki L, Murer H, Forster I . Deciphering PiT transport kinetics and substrate specificity using electrophysiology and flux measurements. Am J Physiol Cell Physiol. 2007; 293(2):C606-20. DOI: 10.1152/ajpcell.00064.2007. View

3.
Capuano P, Radanovic T, Wagner C, Bacic D, Kato S, Uchiyama Y . Intestinal and renal adaptation to a low-Pi diet of type II NaPi cotransporters in vitamin D receptor- and 1alphaOHase-deficient mice. Am J Physiol Cell Physiol. 2005; 288(2):C429-34. DOI: 10.1152/ajpcell.00331.2004. View

4.
Miyamoto K, Ito M, Kuwahata M, Kato S, Segawa H . Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor 23. Ther Apher Dial. 2005; 9(4):331-5. DOI: 10.1111/j.1744-9987.2005.00292.x. View

5.
Cizman B . Hyperphosphataemia and treatment with sevelamer in haemodialysis patients. Nephrol Dial Transplant. 2003; 18 Suppl 5:v47-9. DOI: 10.1093/ndt/gfg1046. View